IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2005;46:2736-2747.)
© 2005 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.04-1489
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Notari, L.
Right arrow Articles by Becerra, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Notari, L.
Right arrow Articles by Becerra, S. P.

Pigment Epithelium–Derived Factor Is a Substrate for Matrix Metalloproteinase Type 2 and Type 9: Implications for Downregulation in Hypoxia

Luigi Notari,1 Amanda Miller,1 Alfredo Martínez,2,3 Juan Amaral,1 Meihua Ju,4 Gregory Robinson,4 Lois E. H. Smith,4 and S. Patricia Becerra1

1From the Laboratory of Retinal Cell and Molecular Biology, National Eye Institute, and the 2Cell and Cancer Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and the 4Department of Ophthalmology, Children’s Hospital, Harvard Medical School, Boston, Massachusetts.

PURPOSE. Pigment epithelium–derived factor (PEDF), a protein secreted by the retinal pigment epithelium (RPE), acts on retinal survival and angiogenesis. Because hypoxia and VEGF regulate matrix metalloproteinases (MMPs), their effects on PEDF proteolysis were explored.

METHODS. Mouse models for retinopathy of prematurity (ROP) were used. Cultured monkey RPE cells were exposed to low oxygen and chemical hypoxia mimetics. PEDF and VEGF mRNA levels in RPE were determined by RT-PCR. MMPs were assessed by zymography, DQ-gelatin degradation solution assays, and MMP immunostaining. PEDF proteolysis was assayed in solution and followed by SDS-PAGE and immunostaining. MMP induction by VEGF was performed in baby hamster kidney (BHK) cells. Retinal R28 cell survival, ex vivo chick embryonic aortic vessel sprouting, and directed in vivo angiogenesis assays were performed.

RESULTS. Levels of PEDF in RPE/choroid significantly decreased in the ROP model. Hypoxia decreased PEDF levels in the media conditioned by RPE cells, with no significant change in PEDF mRNA. Conversely, PEDF proteolysis, gelatinolytic activities of ~57-kDa and ~86-kDa zymogens, and MMP-2 immunoreactivities increased with hypoxia. Addition of VEGF to BHK cells caused a time and dose-related upregulation of ~57-kDa zymogens and of DQ-gelatinolytic and PEDF-degrading activity. The PEDF-degrading activity and ~57-kDa zymogens in the BHK media shared MMP protease inhibition patterns and MMP-2 immunoreactivities with those in the vitreous. Limited proteolysis with MMP-2 and -9 degraded PEDF in a Ca+2-dependent fashion. MMP-mediated proteolysis of PEDF abolished the retinal survival and antiangiogenic activities of the PEDF protein.

CONCLUSIONS. Hypoxia and VEGF can downregulate PEDF through proteolytic degradation. PEDF is a novel substrate for MMP-2 and -9. These results reveal a novel posttranslational mechanism for downregulating PEDF, and provide an explanation for hypoxia-provoked increases in VEGF/PEDF ratios, in angiogenesis and/or in neuronal death.




This article has been cited by other articles:


Home page
 IOVSHome page
J. Lange, Y. Yafai, A. Reichenbach, P. Wiedemann, and W. Eichler
Regulation of Pigment Epithelium-Derived Factor Production and Release by Retinal Glial (Muller) Cells under Hypoxia
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 5161 - 5167.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
J. V. Cockle, N. Gopichandran, J. J. Walker, M. I. Levene, and N. M. Orsi
Matrix Metalloproteinases and Their Tissue Inhibitors in Preterm Perinatal Complications
Reproductive Sciences, October 1, 2007; 14(7): 629 - 645.
[Abstract] [PDF]

Home page
 Eur Respir JHome page
W-Y. Hsieh, M-W. Chen, H-T. Ho, T-M. You, and Y-T. Lu
Identification of differentially expressed proteins in human malignant pleural effusions
Eur. Respir. J., December 1, 2006; 28(6): 1178 - 1185.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Martinez, J. A. Bengoechea, and F. Cuttitta
Molecular Evolution of Proadrenomedullin N-Terminal 20 Peptide (PAMP): Evidence for Gene Co-Option
Endocrinology, July 1, 2006; 147(7): 3457 - 3461.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Association for Research in Vision and Ophthalmology